CLINICAL_TRIALS
ClinicalTrials.gov record update
A Controlled, Randomized, Double-Blinded, Within-Subject, Multicenter, Prospective Clinical Study of TEOSYAL® RHA Global Action and TEOSYAL® RHA Deep Lines Versus Juvéderm® Ultra XC in the Treatment of Moderate to Severe Nasolabial Folds
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02195427
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:56.988087+00:00
- Published At
- 2018-03-26T00:00:00+00:00
- Record Updated At
- 2018-04-25
- Results Posted At
- 2018-03-26
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Nasolabial Folds, Wrinkles"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-04-25"- protocolSection.identificationModule.nctId
"NCT02195427"- protocolSection.identificationModule.officialTitle
"A Controlled, Randomized, Double-Blinded, Within-Subject, Multicenter, Prospective Clinical Study of TEOSYAL\u00ae RHA Global Action and TEOSYAL\u00ae RHA Deep Lines Versus Juv\u00e9derm\u00ae Ultra XC in the Treatment of Moderate to Severe Nasolabial Folds"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-03-26"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.